In the subgroup of patients with diabetes, individuals with overweight and obesity were less likely to receive insulin therapy and to have peripheral vascular disease, multi-vessel coronary disease than normal-weight individuals (P < 0.05). Here, INS is linked to obesity due to melanocortin 4 receptor deficiency.